Key Points
- President Michael Moore sold 31,570 shares on March 18 for $297,389.40 (a reported 1.83% ownership drop); across March 18–20 he sold a total of 136,802 shares for about $1.24M, leaving him with 1,691,044 shares (~$15.93M).
- VMD traded down 5.5% (opened $8.71) and the company has a market capitalization of $336.2M, a P/E of 23.5, 50/200-day SMAs of $8.30/$7.37, and a 12‑month range of $5.93–$10.06.
- The company beat EPS estimates for the quarter ($0.14 vs. $0.12) but missed revenue ($76.18M vs. $77.70M); institutional investors own 74.24% of the stock and the analyst consensus remains a Hold despite some recent upgrades.
Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) President Michael Moore sold 31,570 shares of the company's stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $9.42, for a total value of $297,389.40. Following the transaction, the president directly owned 1,691,044 shares of the company's stock, valued at $15,929,634.48. This trade represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Michael Moore also recently made the following trade(s):
- On Friday, March 20th, Michael Moore sold 65,000 shares of Viemed Healthcare stock. The stock was sold at an average price of $8.77, for a total value of $570,050.00.
- On Thursday, March 19th, Michael Moore sold 40,232 shares of Viemed Healthcare stock. The stock was sold at an average price of $9.21, for a total value of $370,536.72.
Viemed Healthcare Trading Down 5.5%
NASDAQ:VMD opened at $8.71 on Friday. The firm has a market capitalization of $336.23 million, a P/E ratio of 23.54 and a beta of 1.23. The business has a 50 day simple moving average of $8.30 and a 200 day simple moving average of $7.37. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.18 and a quick ratio of 1.06. Viemed Healthcare, Inc. has a 12-month low of $5.93 and a 12-month high of $10.06.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The firm had revenue of $76.18 million for the quarter, compared to analyst estimates of $77.70 million. Viemed Healthcare had a return on equity of 10.72% and a net margin of 5.53%.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of VMD. Segall Bryant & Hamill LLC acquired a new position in Viemed Healthcare during the third quarter worth about $1,965,000. Wasatch Advisors LP boosted its position in shares of Viemed Healthcare by 18.4% during the 2nd quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company's stock valued at $10,683,000 after purchasing an additional 240,346 shares in the last quarter. Forager Capital Management LLC boosted its position in shares of Viemed Healthcare by 12.1% during the 2nd quarter. Forager Capital Management LLC now owns 2,136,472 shares of the company's stock valued at $14,763,000 after purchasing an additional 230,670 shares in the last quarter. Two Sigma Investments LP grew its stake in shares of Viemed Healthcare by 193.7% in the 3rd quarter. Two Sigma Investments LP now owns 251,410 shares of the company's stock worth $1,707,000 after purchasing an additional 165,797 shares during the last quarter. Finally, Rothschild Wealth LLC acquired a new position in shares of Viemed Healthcare in the 4th quarter worth approximately $967,000. Institutional investors own 74.24% of the company's stock.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. Weiss Ratings reiterated a "hold (c)" rating on shares of Viemed Healthcare in a research report on Monday, December 29th. Wall Street Zen upgraded shares of Viemed Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, February 14th. Finally, Zacks Research upgraded shares of Viemed Healthcare to a "hold" rating in a research note on Thursday, January 8th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of "Hold".
Get Our Latest Analysis on Viemed Healthcare
Viemed Healthcare Company Profile
(
Get Free Report)
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
